{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,23]],"date-time":"2025-10-23T13:16:53Z","timestamp":1761225413234,"version":"build-2065373602"},"reference-count":46,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"name":"Kelleigh\u2019s Cause Foundation"}],"content-domain":{"domain":["bmn.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Drug Discovery Today"],"published-print":{"date-parts":[[2021,8]]},"DOI":"10.1016\/j.drudis.2020.12.012","type":"journal-article","created":{"date-parts":[[2020,12,24]],"date-time":"2020-12-24T03:33:40Z","timestamp":1608780820000},"page":"1790-1793","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["RhoA activation-mediated vascular permeability in capillary malformation-arteriovenous malformation syndrome: a hypothesis"],"prefix":"10.1016","volume":"26","author":[{"given":"Shahram","family":"Eisa-Beygi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nghia (Jack)","family":"Vo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Brian A.","family":"Link","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.drudis.2020.12.012_bib0005","doi-asserted-by":"crossref","first-page":"1240","DOI":"10.1086\/379793","article-title":"Capillary malformation-arteriovenous malformation, a new clinical and genetic disorder caused by RASA1 mutations","volume":"73","author":"Eerola","year":"2003","journal-title":"Am. J. Hum. Genet."},{"key":"10.1016\/j.drudis.2020.12.012_bib0010","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1001\/jamadermatol.2019.0319","article-title":"Capillary malformation-arteriovenous malformation syndrome","volume":"155","author":"Sibley","year":"2019","journal-title":"JAMA Dermatol."},{"key":"10.1016\/j.drudis.2020.12.012_bib0015","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1016\/j.braindev.2019.06.003","article-title":"Novel RASA1 mutations in Japanese pedigrees with capillary malformation-arteriovenous malformation","volume":"41","author":"Moteki","year":"2019","journal-title":"Brain Dev."},{"key":"10.1016\/j.drudis.2020.12.012_bib0020","doi-asserted-by":"crossref","first-page":"1521","DOI":"10.1038\/s41431-018-0196-1","article-title":"Expanding the clinical and molecular findings in RASA1 capillary malformation-arteriovenous malformation","volume":"26","author":"Wooderchak-Donahue","year":"2018","journal-title":"Eur. J. Hum. Genet."},{"key":"10.1016\/j.drudis.2020.12.012_bib0025","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1055\/s-0037-1604299","article-title":"New treatment approaches to arteriovenous malformations","volume":"34","author":"Gilbert","year":"2017","journal-title":"Semin. Intervent. Radiol."},{"key":"10.1016\/j.drudis.2020.12.012_bib0030","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1002\/humu.20746","article-title":"Parkes Weber syndrome, vein of Galen aneurysmal malformation, and other fast-flow vascular anomalies are caused by RASA1 mutations","volume":"29","author":"Revencu","year":"2008","journal-title":"Hum. Mutat."},{"key":"10.1016\/j.drudis.2020.12.012_bib0035","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1056\/NEJMoa1709449","article-title":"Somatic activating KRAS mutations in arteriovenous malformations of the brain","volume":"378","author":"Nikolaev","year":"2018","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.drudis.2020.12.012_bib0040","first-page":"469","article-title":"Regulation of cell cycle progression and apoptosis by the Ras\/Raf\/MEK\/ERK pathway","volume":"22","author":"Chang","year":"2003","journal-title":"Int. J. Oncol."},{"key":"10.1016\/j.drudis.2020.12.012_bib0045","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1038\/ng.115","article-title":"Differential effects of oncogenic K-Ras and N-Ras on proliferation, differentiation and tumor progression in the colon","volume":"40","author":"Haigis","year":"2008","journal-title":"Nat. Genet."},{"key":"10.1016\/j.drudis.2020.12.012_bib0050","doi-asserted-by":"crossref","first-page":"2969","DOI":"10.1158\/0008-5472.CAN-19-3682","article-title":"The frequency of Ras mutations in cancer","volume":"80","author":"Prior","year":"2020","journal-title":"Cancer Res."},{"key":"10.1016\/j.drudis.2020.12.012_bib0055","doi-asserted-by":"crossref","first-page":"2869","DOI":"10.1016\/j.celrep.2018.08.025","article-title":"Activation of Ras in the vascular endothelium induces brain vascular malformations and hemorrhagic stroke","volume":"24","author":"Li","year":"2018","journal-title":"Cell Rep."},{"key":"10.1016\/j.drudis.2020.12.012_bib0060","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1038\/nm.2186","article-title":"MicroRNA-132-mediated loss of p120RasGAP activates the endothelium to facilitate pathological angiogenesis","volume":"16","author":"Anand","year":"2010","journal-title":"Nat. Med."},{"key":"10.1016\/j.drudis.2020.12.012_bib0065","doi-asserted-by":"crossref","first-page":"F487","DOI":"10.1152\/ajprenal.00112.2008","article-title":"Cytokine-induced F-actin reorganization in endothelial cells involves RhoA activation","volume":"296","author":"Campos","year":"2009","journal-title":"Am. J. Physiol. Renal Physiol."},{"key":"10.1016\/j.drudis.2020.12.012_bib0070","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1161\/CIRCRESAHA.107.156513","article-title":"Endogenous RhoA inhibitor protects endothelial barrier","volume":"101","author":"van Nieuw Amerongen","year":"2007","journal-title":"Circ. Res."},{"key":"10.1016\/j.drudis.2020.12.012_bib0075","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1016\/j.drudis.2010.06.011","article-title":"Rho-kinase inhibition: a novel therapeutic target for the treatment of cardiovascular diseases","volume":"15","author":"Dong","year":"2010","journal-title":"Drug Discov. Today"},{"key":"10.1016\/j.drudis.2020.12.012_bib0080","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1084\/jem.20091258","article-title":"Cerebral cavernous malformations proteins inhibit Rho kinase to stabilize vascular integrity","volume":"207","author":"Stockton","year":"2010","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.drudis.2020.12.012_bib0085","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.18632\/aging.101819","article-title":"RhoA in aneurysmal subarachnoid hemorrhage","volume":"11","author":"Ure\u00f1a","year":"2019","journal-title":"Aging"},{"key":"10.1016\/j.drudis.2020.12.012_bib0090","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1177\/0271678X16679169","article-title":"Inhibition of stress fiber formation preserves blood-brain barrier after intracerebral hemorrhage in mice","volume":"38","author":"Manaenko","year":"2018","journal-title":"J. Cereb. Blood Flow Metab."},{"key":"10.1016\/j.drudis.2020.12.012_bib0095","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/j.bbrc.2012.07.063","article-title":"PKC and RhoA signals cross-talk in Escherichia coli endotoxin induced alterations in brain endothelial permeability","volume":"425","author":"He","year":"2012","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.drudis.2020.12.012_bib0100","doi-asserted-by":"crossref","first-page":"e42","DOI":"10.1016\/j.thromres.2013.03.010","article-title":"Unfractionated heparin attenuates lung vascular leak in a mouse model of sepsis: role of RhoA\/Rho kinase pathway","volume":"132","author":"Han","year":"2013","journal-title":"Thromb. Res."},{"key":"10.1016\/j.drudis.2020.12.012_bib0105","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.jneuroim.2011.08.015","article-title":"The effects of fasudil on the permeability of the rat blood-brain barrier and blood-spinal cord barrier following experimental autoimmune encephalomyelitis","volume":"239","author":"Huang","year":"2011","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.drudis.2020.12.012_bib0110","doi-asserted-by":"crossref","first-page":"100765","DOI":"10.1016\/j.isci.2019.100765","article-title":"Ebola hemorrhagic shock syndrome-on-a-chip","volume":"23","author":"Junaid","year":"2020","journal-title":"iScience"},{"key":"10.1016\/j.drudis.2020.12.012_bib0115","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1038\/377695a0","article-title":"Vascular system defects and neuronal apoptosis in mice lacking ras GTPase-activating protein","volume":"377","author":"Henkemeyer","year":"1995","journal-title":"Nature"},{"key":"10.1016\/j.drudis.2020.12.012_bib0120","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1172\/JCI46116","article-title":"RASA1 maintains the lymphatic vasculature in a quiescent functional state in mice","volume":"122","author":"Lapinski","year":"2012","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.drudis.2020.12.012_bib0125","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1038\/359153a0","article-title":"Association between GTPase activators for Rho and Ras families","volume":"359","author":"Settleman","year":"1992","journal-title":"Nature"},{"key":"10.1016\/j.drudis.2020.12.012_bib0130","doi-asserted-by":"crossref","first-page":"3073","DOI":"10.1002\/j.1460-2075.1993.tb05976.x","article-title":"The N-terminal region of GAP regulates cytoskeletal structure and cell adhesion","volume":"12","author":"McGlade","year":"1993","journal-title":"EMBO J."},{"key":"10.1016\/j.drudis.2020.12.012_bib0135","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1016\/j.cell.2007.05.018","article-title":"GEFs and GAPs: critical elements in the control of small G proteins","volume":"129","author":"Bos","year":"2007","journal-title":"Cell"},{"key":"10.1016\/j.drudis.2020.12.012_bib0140","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1152\/physrev.00003.2012","article-title":"Regulation of small GTPases by GEFs, GAPs, and GDIs","volume":"93","author":"Cherfils","year":"2013","journal-title":"Physiol. Rev."},{"key":"10.1016\/j.drudis.2020.12.012_bib0145","doi-asserted-by":"crossref","first-page":"17947","DOI":"10.1074\/jbc.270.30.17947","article-title":"Two SH2 domains of p120 Ras GTPase-activating protein bind synergistically to tyrosine phosphorylated p190 Rho GTPase-activating protein","volume":"270","author":"Bryant","year":"1995","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.drudis.2020.12.012_bib0150","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1093\/emboj\/16.3.473","article-title":"Tandem SH2 binding sites mediate the RasGAP-RhoGAP interaction: a conformational mechanism for SH3 domain regulation","volume":"16","author":"Hu","year":"1997","journal-title":"EMBO J."},{"key":"10.1016\/j.drudis.2020.12.012_bib0155","doi-asserted-by":"crossref","first-page":"1852","DOI":"10.1242\/jcs.046870","article-title":"A FAK-p120RasGAP-p190RhoGAP complex regulates polarity in migrating cells","volume":"122","author":"Tomar","year":"2009","journal-title":"J. Cell. Sci."},{"key":"10.1016\/j.drudis.2020.12.012_bib0160","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1083\/jcb.200202117","article-title":"Localized suppression of RhoA activity by Tyr31\/118-phosphorylated paxillin in cell adhesion and migration","volume":"159","author":"Tsubouchi","year":"2002","journal-title":"J. Cell Biol."},{"key":"10.1016\/j.drudis.2020.12.012_bib0165","doi-asserted-by":"crossref","first-page":"1318","DOI":"10.1038\/sj.onc.1203422","article-title":"RAFTK\/Pyk2 tyrosine kinase mediates the association of p190 RhoGAP with RasGAP and is involved in breast cancer cell invasion","volume":"19","author":"Zrihan-Licht","year":"2000","journal-title":"Oncogene"},{"key":"10.1016\/j.drudis.2020.12.012_bib0170","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1046\/j.1432-1327.1999.00689.x","article-title":"Formation of complexes involving RasGAP and p190 RhoGAP during morphogenetic events of the gastrulation in xenopus","volume":"265","author":"Dupont","year":"1999","journal-title":"Eur. J. Biochem."},{"key":"10.1016\/j.drudis.2020.12.012_bib0175","doi-asserted-by":"crossref","first-page":"e0226113","DOI":"10.1371\/journal.pone.0226113","article-title":"Crystal structures of p120RasGAP N-terminal SH2 domain in its apo form and in complex with a p190RhoGAP phosphotyrosine peptide","volume":"14","author":"Chehayeb","year":"2019","journal-title":"PLoS One"},{"key":"10.1016\/j.drudis.2020.12.012_bib0180","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1158\/1541-7786.MCR-15-0456","article-title":"Transcriptional regulation of miR-31 by oncogenic KRAS mediates metastatic phenotypes by repressing RASA1","volume":"14","author":"Kent","year":"2016","journal-title":"Mol. Cancer Res."},{"key":"10.1016\/j.drudis.2020.12.012_bib0185","first-page":"2289","article-title":"Critical role of Rho in cell transformation by oncogenic Ras","volume":"10","author":"Prendergast","year":"1995","journal-title":"Oncogene"},{"key":"10.1016\/j.drudis.2020.12.012_bib0190","doi-asserted-by":"crossref","first-page":"2807","DOI":"10.1074\/jbc.M207943200","article-title":"Oncogenic Ras leads to Rho activation by activating the mitogen-activated protein kinase pathway and decreasing Rho-GTPase-activating protein activity","volume":"278","author":"Chen","year":"2003","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.drudis.2020.12.012_bib0195","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1083\/jcb.130.2.355","article-title":"c-Src regulates the simultaneous rearrangement of actin cytoskeleton, p190RhoGAP, and p120RasGAP following epidermal growth factor stimulation","volume":"130","author":"Chang","year":"1995","journal-title":"J. Cell Biol."},{"key":"10.1016\/j.drudis.2020.12.012_bib0200","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1016\/j.biochi.2008.10.010","article-title":"p120-Ras GTPase activating protein (RasGAP): a multi-interacting protein in downstream signaling","volume":"91","author":"Pamonsinlapatham","year":"2009","journal-title":"Biochimie"},{"key":"10.1016\/j.drudis.2020.12.012_bib0205","doi-asserted-by":"crossref","first-page":"1323","DOI":"10.1016\/j.drudis.2013.09.010","article-title":"Advances in the development of Rho-associated protein kinase (ROCK) inhibitors","volume":"18","author":"Pan","year":"2013","journal-title":"Drug Discov. Today"},{"key":"10.1016\/j.drudis.2020.12.012_bib0210","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.jns.2005.06.003","article-title":"Effects of fasudil in acute ischemic stroke: results of a prospective placebo-controlled double-blind trial","volume":"238","author":"Shibuya","year":"2005","journal-title":"J. Neurol. Sci."},{"key":"10.1016\/j.drudis.2020.12.012_bib0215","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/j.surneu.2006.10.037","article-title":"A postmarketing surveillance study of fasudil treatment after aneurysmal subarachnoid hemorrhage","volume":"68","author":"Suzuki","year":"2007","journal-title":"Surg. Neurol."},{"key":"10.1016\/j.drudis.2020.12.012_bib0220","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/j.drudis.2014.10.002","article-title":"Farnesyltransferase and geranylgeranyltransferase I: structures, mechanism, inhibitors and molecular modeling","volume":"20","author":"Shen","year":"2015","journal-title":"Drug Discov. Today"},{"key":"10.1016\/j.drudis.2020.12.012_bib0225","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1042\/BST20170531","article-title":"RHO GTPases in cancer: known facts, open questions, and therapeutic challenges","volume":"46","author":"Bustelo","year":"2018","journal-title":"Biochem. Soc. Trans"},{"key":"10.1016\/j.drudis.2020.12.012_bib0230","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1016\/j.drudis.2010.05.012","article-title":"Therapeutic modulation of k-ras signaling in colorectal cancer","volume":"15","author":"Krens","year":"2010","journal-title":"Drug Discov. Today"}],"container-title":["Drug Discovery Today"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1359644620305304?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1359644620305304?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,23]],"date-time":"2025-10-23T12:54:51Z","timestamp":1761224091000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1359644620305304"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,8]]},"references-count":46,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2021,8]]}},"alternative-id":["S1359644620305304"],"URL":"https:\/\/doi.org\/10.1016\/j.drudis.2020.12.012","relation":{},"ISSN":["1359-6446"],"issn-type":[{"type":"print","value":"1359-6446"}],"subject":[],"published":{"date-parts":[[2021,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"RhoA activation-mediated vascular permeability in capillary malformation-arteriovenous malformation syndrome: a hypothesis","name":"articletitle","label":"Article Title"},{"value":"Drug Discovery Today","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.drudis.2020.12.012","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}